Media-OutReach Newswire Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China
Media-OutReach Newswire Hang Chi 2018 Interim Revenue Soars 44.69% to HK$65.91 million Profit for the Period Shoots Up 182.94%
Media-OutReach Newswire Aruba Introduces Integrated SD-WAN, LAN and Security Solution to Power the Software-Defined Branch